184 related articles for article (PubMed ID: 16522890)
21. [Encounter of cancer cells with bone. Cancer treatment-induced bone loss : CTIBL].
Takahashi S
Clin Calcium; 2011 Mar; 21(3):447-53. PubMed ID: 21358067
[TBL] [Abstract][Full Text] [Related]
22. Validation of JSBMR's CTIBL manual for Japanese men receiving androgen deprivation therapy for prostate cancer.
Matsushima H
J Bone Miner Metab; 2023 Nov; 41(6):822-828. PubMed ID: 37498323
[TBL] [Abstract][Full Text] [Related]
23. Nursing implications of androgen deprivation therapy-associated bone loss.
Weingard KK
Urol Nurs; 2006 Aug; 26(4):261-9; quiz 270. PubMed ID: 16939043
[TBL] [Abstract][Full Text] [Related]
24. Androgen deprivation in prostate cancer and the long-term risk of fracture.
Ojeda S; Lloret M; Naranjo A; Déniz F; Chesa N; Domínguez C; Lara PC
Actas Urol Esp; 2017 Oct; 41(8):491-496. PubMed ID: 28259363
[TBL] [Abstract][Full Text] [Related]
25. Antiresorptive therapy in the management of cancer treatment-induced bone loss.
Garg A; Leitzel K; Ali S; Lipton A
Curr Osteoporos Rep; 2015 Apr; 13(2):73-7. PubMed ID: 25575469
[TBL] [Abstract][Full Text] [Related]
26. Osteoporosis: new hope for the future.
Masi L; Bilezikian JP
Int J Fertil Womens Med; 1997; 42(4):245-54. PubMed ID: 9309458
[TBL] [Abstract][Full Text] [Related]
27. Cancer Treatment and Bone Health.
Handforth C; D'Oronzo S; Coleman R; Brown J
Calcif Tissue Int; 2018 Feb; 102(2):251-264. PubMed ID: 29353450
[TBL] [Abstract][Full Text] [Related]
28. Management of cancer treatment-induced bone loss (CTIBL) in patients with breast cancer or prostate cancer.
Takahashi S
J Bone Miner Metab; 2023 May; 41(3):307-316. PubMed ID: 37036530
[TBL] [Abstract][Full Text] [Related]
29. [Prostate cancer and Cancer Treatment-Induced Bone Loss(CTIBL)].
Matsushima H
Clin Calcium; 2016 Jul; 26(7):1039-45. PubMed ID: 27346316
[TBL] [Abstract][Full Text] [Related]
30. Bone health and adherence to vitamin D and calcium therapy in early breast cancer patients on endocrine therapy with aromatase inhibitors.
Bošković L; Gašparić M; Petković M; Gugić D; Lovasić IB; Soldić Ž; Miše BP; Dabelić N; Vazdar L; Vrdoljak E
Breast; 2017 Feb; 31():16-19. PubMed ID: 27810693
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological management of osteoporosis in postmenopausal women: a comparative review.
Reid IR
Drugs Aging; 1999 Nov; 15(5):349-63. PubMed ID: 10600043
[TBL] [Abstract][Full Text] [Related]
32. Denosumab and the current status of bone-modifying drugs in breast cancer.
Lee BL; Higgins MJ; Goss PE
Acta Oncol; 2012 Feb; 51(2):157-67. PubMed ID: 22150116
[TBL] [Abstract][Full Text] [Related]
33. Pathophysiology and implications of cancer treatment-induced bone loss.
Theriault RL
Oncology (Williston Park); 2004 May; 18(5 Suppl 3):11-5. PubMed ID: 15202582
[TBL] [Abstract][Full Text] [Related]
34. Prevention and treatment of bone loss in patients with nonmetastatic breast or prostate cancer who receive hormonal ablation therapy.
Limburg C; Maxwell C; Mautner B
Clin J Oncol Nurs; 2014 Apr; 18(2):223-30. PubMed ID: 24675258
[TBL] [Abstract][Full Text] [Related]
35. In whom and how to prevent glucocorticoid-induced osteoporosis.
Adachi JD; Papaioannou A
Best Pract Res Clin Rheumatol; 2005 Dec; 19(6):1039-64. PubMed ID: 16301196
[TBL] [Abstract][Full Text] [Related]
36. Osteoporosis management.
Rozenberg S; Vandromme J; Ayata NB; Filippidis M; Kroll M
Int J Fertil Womens Med; 1999; 44(5):241-9. PubMed ID: 10569453
[TBL] [Abstract][Full Text] [Related]
37. Prevention of bone loss and vertebral fractures in patients with chronic epilepsy--antiepileptic drug and osteoporosis prevention trial.
Lazzari AA; Dussault PM; Thakore-James M; Gagnon D; Baker E; Davis SA; Houranieh AM
Epilepsia; 2013 Nov; 54(11):1997-2004. PubMed ID: 24010637
[TBL] [Abstract][Full Text] [Related]
38. Cancer treatment-induced bone loss in premenopausal women: a need for therapeutic intervention?
Hadji P; Gnant M; Body JJ; Bundred NJ; Brufsky A; Coleman RE; Guise TA; Lipton A; Aapro MS
Cancer Treat Rev; 2012 Oct; 38(6):798-806. PubMed ID: 22429722
[TBL] [Abstract][Full Text] [Related]
39. How to prevent glucocorticoid-induced osteoporosis.
Dore RK
Cleve Clin J Med; 2010 Aug; 77(8):529-36. PubMed ID: 20682515
[TBL] [Abstract][Full Text] [Related]
40. MRONJ in breast cancer patients under bone modifying agents for cancer treatment-induced bone loss (CTIBL): a multi-hospital-based case series.
Mauceri R; Coppini M; Attanasio M; Bedogni A; Bettini G; Fusco V; Giudice A; Graziani F; Marcianò A; Nisi M; Isola G; Leonardi RM; Oteri G; Toro C; Campisi G
BMC Oral Health; 2023 Feb; 23(1):71. PubMed ID: 36739399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]